Log In
Print this Print this

PreTRM test

  Manage Alerts
Collapse Summary General Information
Company Sera Prognostics Inc.
DescriptionBlood test for detecting the risk of spontaneous preterm birth in asymptomatic, singleton pregnancies based on a signature of the insulin-like growth factor binding protein-4 (IGFBP4) and sex hormone-binding globulin (SHBG; SBP)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationGenitourinary, Diagnostic
Indication DetailsAssess the risk of spontaneous preterm birth in women with singleton pregnancies
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today